BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 18818406)

  • 41. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
    Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
    Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human and Murine Interleukin 23 Receptors Are Novel Substrates for A Disintegrin and Metalloproteases ADAM10 and ADAM17.
    Franke M; Schröder J; Monhasery N; Ackfeld T; Hummel TM; Rabe B; Garbers C; Becker-Pauly C; Floss DM; Scheller J
    J Biol Chem; 2016 May; 291(20):10551-61. PubMed ID: 26961870
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling.
    Bozkulak EC; Weinmaster G
    Mol Cell Biol; 2009 Nov; 29(21):5679-95. PubMed ID: 19704010
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion.
    Xiao LJ; Lin P; Lin F; Liu X; Qin W; Zou HF; Guo L; Liu W; Wang SJ; Yu XG
    Int J Oncol; 2012 May; 40(5):1714-24. PubMed ID: 22200661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential surface expression of ADAM10 and ADAM17 on human T lymphocytes and tumor cells.
    Ebsen H; Schröder A; Kabelitz D; Janssen O
    PLoS One; 2013; 8(10):e76853. PubMed ID: 24130797
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin-like growth factor-1 (IGF-1)-induced processing of amyloid-beta precursor protein (APP) and APP-like protein 2 is mediated by different metalloproteinases.
    Jacobsen KT; Adlerz L; Multhaup G; Iverfeldt K
    J Biol Chem; 2010 Apr; 285(14):10223-31. PubMed ID: 20139073
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vascular endothelial growth factor receptor 2 direct interaction with nephrin links VEGF-A signals to actin in kidney podocytes.
    Bertuccio C; Veron D; Aggarwal PK; Holzman L; Tufro A
    J Biol Chem; 2011 Nov; 286(46):39933-44. PubMed ID: 21937443
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The "A Disintegrin And Metalloproteases" ADAM10 and ADAM17: novel drug targets with therapeutic potential?
    Saftig P; Reiss K
    Eur J Cell Biol; 2011; 90(6-7):527-35. PubMed ID: 21194787
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ADAM10 is the major sheddase responsible for the release of membrane-associated meprin A.
    Herzog C; Haun RS; Ludwig A; Shah SV; Kaushal GP
    J Biol Chem; 2014 May; 289(19):13308-22. PubMed ID: 24662289
    [TBL] [Abstract][Full Text] [Related]  

  • 50. L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth.
    Maretzky T; Schulte M; Ludwig A; Rose-John S; Blobel C; Hartmann D; Altevogt P; Saftig P; Reiss K
    Mol Cell Biol; 2005 Oct; 25(20):9040-53. PubMed ID: 16199880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling.
    Benedito R; Rocha SF; Woeste M; Zamykal M; Radtke F; Casanovas O; Duarte A; Pytowski B; Adams RH
    Nature; 2012 Mar; 484(7392):110-4. PubMed ID: 22426001
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells.
    Raimondi C; Fantin A; Lampropoulou A; Denti L; Chikh A; Ruhrberg C
    J Exp Med; 2014 Jun; 211(6):1167-83. PubMed ID: 24863063
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phosphorylation of Akt and ERK1/2 is required for VEGF-A/VEGFR2-induced proliferation and migration of lymphatic endothelium.
    Dellinger MT; Brekken RA
    PLoS One; 2011; 6(12):e28947. PubMed ID: 22174934
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Self-control of HGF regulation on human trophoblast cell invasion via enhancing c-Met receptor shedding by ADAM10 and ADAM17.
    Yang Y; Wang Y; Zeng X; Ma XJ; Zhao Y; Qiao J; Cao B; Li YX; Ji L; Wang YL
    J Clin Endocrinol Metab; 2012 Aug; 97(8):E1390-401. PubMed ID: 22689693
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ectodomain shedding of Fcalpha receptor is mediated by ADAM10 and ADAM17.
    Peng M; Guo S; Yin N; Xue J; Shen L; Zhao Q; Zhang W
    Immunology; 2010 May; 130(1):83-91. PubMed ID: 20059578
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuropilin-1 aggravates liver cirrhosis by promoting angiogenesis via VEGFR2-dependent PI3K/Akt pathway in hepatic sinusoidal endothelial cells.
    Wang L; Feng Y; Xie X; Wu H; Su XN; Qi J; Xin W; Gao L; Zhang Y; Shah VH; Zhu Q
    EBioMedicine; 2019 May; 43():525-536. PubMed ID: 31060904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suppression of angiogenesis and tumor growth by recombinant T4 phages displaying extracellular domain of vascular endothelial growth factor receptor 2.
    Zuo S; Dai G; Wang L; Wen Y; Huang Z; Yang W; Ma W; Ren X
    Arch Virol; 2019 Jan; 164(1):69-82. PubMed ID: 30259141
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sulfated polysaccharide JCS1S2 inhibits angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
    Wang Z; Jin C; Li X; Ding K
    Carbohydr Polym; 2019 Mar; 207():502-509. PubMed ID: 30600033
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer.
    Pruessmeyer J; Ludwig A
    Semin Cell Dev Biol; 2009 Apr; 20(2):164-74. PubMed ID: 18951988
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NRP1 interacts with endoglin and VEGFR2 to modulate VEGF signaling and endothelial cell sprouting.
    Sharma S; Ehrlich M; Zhang M; Blobe GC; Henis YI
    Commun Biol; 2024 Jan; 7(1):112. PubMed ID: 38242992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.